Total Payments
$1,422
2024 Payments
$279.78
Companies
18
Transactions
45
Medicare Patients
949
Medicare Billing
$254,193

Payment Breakdown by Category

Food & Beverage$1,422 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,422 45 100.0%

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $279.78 3 $0 (2024)
Alexion Pharmaceuticals, Inc. $251.37 2 $0 (2017)
AKEBIA THERAPEUTICS INC $188.21 10 $0 (2022)
Amgen Inc. $116.88 5 $0 (2020)
Genentech USA, Inc. $113.56 1 $0 (2019)
Relypsa, Inc. $112.97 7 $0 (2020)
PFIZER INC. $59.55 1 $0 (2017)
Takeda Pharmaceuticals America, Inc. $56.06 4 $0 (2017)
Vertex Pharmaceuticals Incorporated $55.92 1 $0 (2022)
Mallinckrodt LLC $38.49 2 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $279.78 3 Gilead Sciences, Inc. ($279.78)
2022 $99.13 4 Vertex Pharmaceuticals Incorporated ($55.92)
2021 $50.23 3 AKEBIA THERAPEUTICS INC ($25.44)
2020 $119.92 5 Amgen Inc. ($55.50)
2019 $221.50 6 Genentech USA, Inc. ($113.56)
2018 $24.59 2 Relypsa, Inc. ($13.14)
2017 $627.16 22 Alexion Pharmaceuticals, Inc. ($251.37)

All Payment Transactions

45 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
10/24/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $137.33 General
03/04/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $140.33 General
03/04/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $2.12 General
11/04/2022 Vertex Pharmaceuticals Incorporated Food and Beverage In-kind items and services $55.92 General
10/06/2022 AKEBIA THERAPEUTICS INC Auryxia (Drug) Food and Beverage In-kind items and services $12.37 General
Category: Nephrology
06/28/2022 AKEBIA THERAPEUTICS INC Auryxia (Drug) Food and Beverage In-kind items and services $14.07 General
Category: Nephrology
05/10/2022 AKEBIA THERAPEUTICS INC Auryxia (Drug) Food and Beverage In-kind items and services $16.77 General
Category: Nephrology
11/09/2021 Ultragenyx Pharmaceutical Inc. Crysvita (Drug) Food and Beverage In-kind items and services $24.79 General
Category: XLH Metabolic Bone Disorder
05/04/2021 AKEBIA THERAPEUTICS INC Auryxia (Drug) Food and Beverage In-kind items and services $11.15 General
Category: Nephrology
01/12/2021 AKEBIA THERAPEUTICS INC Auryxia (Drug) Food and Beverage In-kind items and services $14.29 General
Category: Nephrology
10/27/2020 AKEBIA THERAPEUTICS INC AURYXIA (Drug) Food and Beverage In-kind items and services $23.83 General
Category: NEPHROLOGY
09/03/2020 Amgen Inc. Parsabiv (Drug) Food and Beverage In-kind items and services $29.43 General
Category: Nephrology
05/20/2020 Amgen Inc. Parsabiv (Drug) Food and Beverage In-kind items and services $26.07 General
Category: Nephrology
02/28/2020 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $16.03 General
Category: Hyperkalemia
01/27/2020 AKEBIA THERAPEUTICS INC AURYXIA (Drug) Food and Beverage In-kind items and services $24.56 General
Category: NEPHROLOGY
11/19/2019 AKEBIA THERAPEUTICS INC AURYXIA (Drug) Food and Beverage Cash or cash equivalent $24.98 General
Category: NEPHROLOGY
11/15/2019 AKEBIA THERAPEUTICS INC AURYXIA (Drug) Food and Beverage Cash or cash equivalent $23.08 General
Category: NEPHROLOGY
11/15/2019 Amgen Inc. Parsabiv (Biological) Food and Beverage In-kind items and services $11.67 General
Category: Nephrology
10/25/2019 AKEBIA THERAPEUTICS INC AURYXIA (Drug) Food and Beverage Cash or cash equivalent $23.11 General
Category: NEPHROLOGY
10/11/2019 Amgen Inc. Parsabiv (Biological) Food and Beverage In-kind items and services $25.10 General
Category: Nephrology
03/12/2019 Genentech USA, Inc. Food and Beverage In-kind items and services $113.56 General
04/09/2018 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $13.14 General
Category: Hyperkalemia
01/25/2018 Takeda Pharmaceuticals U.S.A., Inc. Uloric (Drug) Food and Beverage In-kind items and services $11.45 General
Category: Gout/Rheumatology
12/21/2017 Takeda Pharmaceuticals America, Inc. Uloric (Drug) Food and Beverage In-kind items and services $15.30 General
Category: Gout/Rheumatology
12/18/2017 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $16.93 General
Category: Hyperkalemia

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 112 211 $274,018 $35,690
2022 7 128 224 $291,098 $44,353
2021 8 313 554 $584,321 $76,334
2020 11 396 691 $704,269 $97,816
Total Patients
949
Total Services
1,680
Medicare Billing
$254,193
Procedure Codes
32

All Medicare Procedures & Services

32 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 13 54 $104,770 $14,560 13.9%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 11 32 $78,400 $10,380 13.2%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 39 63 $33,705 $4,528 13.4%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 20 33 $20,675 $3,541 17.1%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 16 16 $18,398 $1,825 9.9%
90935 Hemodialysis procedure with physician evaluation Facility 2023 13 13 $18,070 $856.18 4.7%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 18 57 $121,695 $19,395 15.9%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 21 48 $83,520 $13,493 16.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 24 43 $24,725 $4,177 16.9%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 14 14 $19,813 $2,646 13.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 23 29 $15,515 $1,918 12.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 17 20 $10,100 $1,839 18.2%
90935 Hemodialysis procedure with physician evaluation Facility 2022 11 13 $15,730 $885.02 5.6%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Office 2021 20 105 $224,175 $35,553 15.9%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 60 119 $63,865 $11,537 18.1%
90935 Hemodialysis procedure with one physician evaluation Facility 2021 57 108 $130,680 $7,355 5.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 77 106 $55,690 $7,136 12.8%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 32 32 $45,731 $5,781 12.6%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 35 35 $40,245 $4,512 11.2%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 21 31 $15,475 $2,839 18.3%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Facility 2021 11 18 $8,460 $1,621 19.2%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Office 2020 35 131 $261,740 $34,504 13.2%
90961 Dialysis services (2-3 physician visits per month), patient 20 years of age and older Office 2020 39 88 $121,880 $19,536 16.0%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 67 150 $72,444 $14,422 19.9%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 42 42 $55,110 $7,690 14.0%

About Dr. Molly Fisher, D.O

Dr. Molly Fisher, D.O is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2011. The National Provider Identifier (NPI) number assigned to this provider is 1467749143.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Molly Fisher, D.O has received a total of $1,422 in payments from pharmaceutical and medical device companies, with $279.78 received in 2024. These payments were reported across 45 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,422).

As a Medicare-enrolled provider, Fisher has provided services to 949 Medicare beneficiaries, totaling 1,680 services with total Medicare billing of $254,193. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.

Practice Information

Products in Payments

  • SOLIRIS (Drug) $251.37
  • AURYXIA (Drug) $119.56
  • Veltassa (Drug) $112.97
  • Auryxia (Drug) $81.63
  • Uloric (Drug) $67.51
  • Parsabiv (Biological) $61.38
  • ELIQUIS (Drug) $59.55
  • Parsabiv (Drug) $55.50
  • ACTHAR (Biological) $38.49
  • Edarbi (Drug) $29.46
  • Crysvita (Drug) $24.79
  • RENVELA (Drug) $23.71
  • ZEPATIER (Drug) $19.73
  • SAMSCA (Drug) $14.60
  • ENTRESTO (Drug) $12.80

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Bronx